SofWave Medical Ltd.
SOFWF
$12.75
$1.8516.97%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 57.78% | 56.02% | 43.35% | 26.45% | 19.71% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 57.78% | 56.02% | 43.35% | 26.45% | 19.71% |
| Cost of Revenue | 67.76% | 65.47% | 46.99% | 20.76% | 9.66% |
| Gross Profit | 54.81% | 52.90% | 42.21% | 28.32% | 23.06% |
| SG&A Expenses | 21.69% | 24.03% | 12.19% | 28.77% | 27.11% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 34.38% | 32.15% | 18.64% | 24.65% | 19.06% |
| Operating Income | 4,430.21% | 213.24% | 279.64% | 0.10% | 41.46% |
| Income Before Tax | 959.87% | 197.51% | 225.44% | -22.98% | -28.41% |
| Income Tax Expenses | -156.20% | 6,100.00% | -36.62% | -300.00% | 1,412.50% |
| Earnings from Continuing Operations | 683.21% | 173.83% | 199.15% | -13.12% | -87.47% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 683.21% | 173.83% | 199.15% | -13.12% | -87.47% |
| EBIT | 4,430.21% | 213.24% | 279.64% | 0.10% | 41.46% |
| EBITDA | 110,332.50% | 333.14% | 415.56% | -2.18% | -92.16% |
| EPS Basic | 661.27% | 171.58% | 196.41% | -10.42% | -85.45% |
| Normalized Basic EPS | 923.81% | 194.19% | 222.08% | -20.11% | -27.27% |
| EPS Diluted | 583.82% | 150.00% | 189.69% | -10.42% | -85.45% |
| Normalized Diluted EPS | 830.95% | 183.82% | 209.17% | -20.11% | -27.27% |
| Average Basic Shares Outstanding | 3.74% | 3.39% | 2.83% | 2.31% | 1.00% |
| Average Diluted Shares Outstanding | 17.00% | 16.32% | 14.95% | 2.31% | 1.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |